Qingdao Haier Biomedical Co Ltd
SSE:688139

Watchlist Manager
Qingdao Haier Biomedical Co Ltd Logo
Qingdao Haier Biomedical Co Ltd
SSE:688139
Watchlist
Price: 33.31 CNY 0.48% Market Closed
Market Cap: ¥10.5B

Qingdao Haier Biomedical Co Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Qingdao Haier Biomedical Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Qingdao Haier Biomedical Co Ltd
SSE:688139
EPS (Diluted)
¥0
CAGR 3-Years
-25%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
EPS (Diluted)
¥5
CAGR 3-Years
32%
CAGR 5-Years
49%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
EPS (Diluted)
¥1
CAGR 3-Years
11%
CAGR 5-Years
2%
CAGR 10-Years
15%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
EPS (Diluted)
¥6
CAGR 3-Years
-5%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Andon Health Co Ltd
SZSE:002432
EPS (Diluted)
¥4
CAGR 3-Years
-50%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
EPS (Diluted)
¥1
CAGR 3-Years
-4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Qingdao Haier Biomedical Co Ltd
Glance View

Market Cap
10.5B CNY
Industry
Health Care

Qingdao Haier Biomedical Co Ltd, nestled within the vibrant hub of Qingdao, China, has been a dynamic player in the life sciences and healthcare industry since its inception. Originally part of the expansive Haier Group, known globally for its household appliances, Haier Biomedical has carved out a niche by focusing intently on the intersection of cold chain logistics and biomedical engineering. Its product line is built around the essential needs of the healthcare, pharmaceutical, and research sectors, where precise temperature control is not just an operational nicety but a critical necessity. The company's range of equipment—from ultra-low temperature freezers to blood bank refrigerators and smart cold storage solutions—acts as the backbone for preserving biological samples, vaccines, and medications. By pioneering smart technology integration within these systems, the company effectively meets stringent global standards, ensuring the safety and efficacy of conserved biological materials. The commercial success of Haier Biomedical stems from its dual strategy of deeply engaging with international markets while continuously innovating its product offerings. The company makes money by selling its high-tech storage and transport solutions to a vast array of clients including hospitals, research laboratories, and pharmaceutical manufacturers around the globe. This revenue model is bolstered by its ability to tap into an ever-growing demand for efficient biological storage, driven by global health initiatives and the rising importance of biotech advancements. Meanwhile, its continuous investment in R&D has positioned it as a leader in smart cold chain logistics, enabling it to adapt swiftly to the rapidly evolving landscape of global healthcare needs. By leveraging its technical expertise and maintaining strong relationships with sector stakeholders across the world, Haier Biomedical consistently achieves a robust financial performance, underpinned by its commitment to quality and innovation in the biomedical field.

Intrinsic Value
20.53 CNY
Overvaluation 38%
Intrinsic Value
Price ¥33.31

See Also

What is Qingdao Haier Biomedical Co Ltd's EPS (Diluted)?
EPS (Diluted)
0.8 CNY

Based on the financial report for Dec 31, 2025, Qingdao Haier Biomedical Co Ltd's EPS (Diluted) amounts to 0.8 CNY.

What is Qingdao Haier Biomedical Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-7%

Over the last year, the EPS (Diluted) growth was -31%. The average annual EPS (Diluted) growth rates for Qingdao Haier Biomedical Co Ltd have been -25% over the past three years , -7% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett